Literature DB >> 17327849

Eukaryotic ribosome display with in situ DNA recovery.

Mingyue He1, Michael J Taussig.   

Abstract

Ribosome display is a cell-free technology for the in vitro selection and evolution of proteins encoded by DNA libraries, in which individual nascent proteins (phenotypes) are linked physically to their corresponding mRNA (genotypes) in stable protein-ribosome-mRNA (PRM) complexes. Formation of the complexes can be achieved through deletion of the stop codon of the mRNA, stalling the ribosome at the end of translation; the nascent protein is extended by a spacer such as the immunoglobulin Ckappa domain or others to allow exit through the ribosome tunnel. Through affinity for a ligand, the protein-mRNA coupling permits simultaneous isolation of a functional nascent protein and its translated mRNA; the latter is then converted into cDNA by reverse transcription and amplified for further manipulation, repeated cycles or soluble protein expression. Through the use of PCR-generated libraries, avoiding the need for cloning, ribosome display can be used to both screen very large populations and continuously search for new diversity during subsequent rounds of selection. Additionally, the use of cell-free systems allows the selection of proteins that are toxic or unstable in cells, and proteins with chemical modifications. Ribosome display systems using both prokaryotic and eukaryotic cell extracts have been developed. Examples of the application of eukaryotic systems include the selection and evolution of antibody fragments, DNA binding domains, enzymes, interacting proteins and peptides among others. Here we describe the step-by-step procedure to perform our previously described eukaryotic ribosome display method, which has the distinctive feature of an in situ reverse transcription-PCR (RT-PCR) procedure for DNA recovery from ribosome-bound mRNA. We also introduce a recent, previously unpublished improvement to the procedure in which in situ reverse transcription is combined with sensitive single-primer PCR technology.

Mesh:

Substances:

Year:  2007        PMID: 17327849     DOI: 10.1038/nmeth1001

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  13 in total

1.  Selection of proteins with desired properties from natural proteome libraries using mRNA display.

Authors:  Steven W Cotten; Jianwei Zou; C Alexander Valencia; Rihe Liu
Journal:  Nat Protoc       Date:  2011-07-21       Impact factor: 13.491

2.  Streamlined protocol for mRNA display.

Authors:  Pamela A Barendt; Daphne T W Ng; Casey N McQuade; Casim A Sarkar
Journal:  ACS Comb Sci       Date:  2013-01-25       Impact factor: 3.784

3.  Broad-specificity mRNA-rRNA complementarity in efficient protein translation.

Authors:  Pamela A Barendt; Najaf A Shah; Gregory A Barendt; Casim A Sarkar
Journal:  PLoS Genet       Date:  2012-03-22       Impact factor: 5.917

4.  Characterization of Anti-Citrinin Specific ScFvs Selected from Non-Immunized Mouse Splenocytes by Eukaryotic Ribosome Display.

Authors:  Haiwei Cheng; Yifei Chen; Yi Yang; Xueqiu Chen; Xiaolu Guo; Aifang Du
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 5.  Automation in the high-throughput selection of random combinatorial libraries--different approaches for select applications.

Authors:  Jörn Glökler; Tatjana Schütze; Zoltán Konthur
Journal:  Molecules       Date:  2010-04-08       Impact factor: 4.411

6.  Ribosome display for the rapid generation of high-affinity Zika-neutralizing single-chain antibodies.

Authors:  Adinarayana Kunamneni; Chunyan Ye; Steven B Bradfute; Ravi Durvasula
Journal:  PLoS One       Date:  2018-11-16       Impact factor: 3.240

7.  Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display.

Authors:  Adinarayana Kunamneni; Elizabeth C Clarke; Chunyan Ye; Steven B Bradfute; Ravi Durvasula
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

8.  Selection of anti-sulfadimidine specific ScFvs from a hybridoma cell by eukaryotic ribosome display.

Authors:  Yonghua Qi; Congming Wu; Suxia Zhang; Zhanhui Wang; Siyang Huang; Lei Dai; Shaochen Wang; Lining Xia; Kai Wen; Xingyuan Cao; Yongning Wu; Jianzhong Shen
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

9.  Development of Next-Generation Peptide Binders Using In vitro Display Technologies and Their Potential Applications.

Authors:  Akira Wada
Journal:  Front Immunol       Date:  2013-08-01       Impact factor: 7.561

10.  Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display.

Authors:  Jie Tang; Lin Wang; Anatoliy Markiv; Simon A Jeffs; Hanna Dreja; Áine McKnight; Mingyue He; Angray S Kang
Journal:  Hum Antibodies       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.